However, CBFβ mutations may be under reported, as deletion of its chromosomal loci at 16q22 represents one of the most frequent and earliest genomic alterations observed in breast cancer, affecting roughly 50% of all cases (Cleton-Jansen et al., 2000). The gene discussed is CBFB; the disease is breast carcinoma.